Skip to main content

Biosmart granted Mastercard Letter of Approval for IDEX Pay biometric cards

Oslo, Norway and Seoul, South Korea – 25 November 2024: Global smart card technology company Biosmart has obtained the Letter of Approval (LoA) from Mastercard for its biometric payment card built on the IDEX Pay platform. Biosmart can now move to industrialized production of biometric payment cards.

Biosmart is a Korea based manufacturer with an annual production capacity of 50+ million payment cards. Biosmart is a trusted partner of leading banks in Asia, Middle East, Europe and USA.

IDEX Biometrics differentiated and optimized fingerprint biometrics platform enables manufacturing partners to serve banks with biometric payment cards which are accepted on all EMVCo compliant payment terminals across the globe.

“Making payments easier and more secure for consumers with biometric payment cards, based on the leading technology from IDEX Biometrics, represents a massive opportunity. The interest from banks in the region underpins the commercial opportunity ahead of us” says Henry Kang, Chief Sales Officer at Biosmart. 

“Congratulations to Biosmart on this Mastercard approval for biometric payment cards, this strategic innovation product fits well with Biosmart’s fintech customers across the world,” comments Catharina Eklof, Chief Executive Officer at IDEX Biometrics. “Secure and frictionless payments contribute to transaction and retention increase, critical to banks in today’s competitive payment landscape.”

For further information contact

Marianne Bøe, Head of Investor Relations
E-mail: ir@idexbiometrics.com
Tel: + 47 67 83 91 19

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX) is a global technology leader in fingerprint biometrics, offering authentication solutions across payments, access control, and digital identity. Our solutions bring convenience, security, peace of mind and seamless user experiences to the world. Built on patented and proprietary sensor technologies, integrated circuit designs, and software, our biometric solutions target card-based applications for payments and digital authentication. As an industry-enabler we partner with leading card manufacturers and technology companies to bring our solutions to market.

For more information, visit www.idexbiometrics.com

About Biosmart
Founded in 1971 and located in South Korea, Biosmart has grown to provide a variety of high-end card products from PVC, jewellery, and metal which deliver a luxurious lifestyle to clients. Biosmart is a certified card manufacturing and personalization vendor of global payment brands such as Visa, Mastercard, AMEX, Union Pay, JCB, and Diner’s.

Trademark Statement
IDEX, IDEX Biometrics and the IDEX logo are trademarks owned by IDEX Biometrics ASA. All other brands or product names are the property of their respective holders.

About this notice
This notice was issued by Marianne Bøe, Head of Investor Relations, on 25 November 2024 at 08:15 CET on behalf of IDEX Biometrics ASA.

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.